Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Vita Life Sciences Limited ( (AU:VLS) ) is now available.
Vita Life Sciences Limited has issued an updated notification regarding its ongoing on-market share buy-back program for its ordinary fully paid shares on the ASX. The company reported that a total of 835,913 shares had been repurchased prior to the previous trading day, with an additional 16,715 shares bought back on the previous day as part of its capital management strategy.
This daily update, dated 24 April 2026, follows the initial buy-back notification lodged in May 2025 and confirms continued execution of the program after the last update on 20 April 2026. The steady pace of repurchases indicates Vita Life Sciences’ ongoing commitment to returning capital to shareholders and potentially improving earnings per share through a reduced share count.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an ASX-listed company in the life sciences sector, trading under the code VLS with ordinary fully paid shares. The company operates in the broader healthcare and pharmaceuticals investment space, using capital management tools such as on-market share buy-backs to optimise its capital structure and enhance shareholder value.
Average Trading Volume: 18,008
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$137M
For a thorough assessment of VLS stock, go to TipRanks’ Stock Analysis page.